Therapeutic potential of chemokine signal inhibition for metastatic breast cancer
Open Access
- 1 October 2015
- journal article
- review article
- Published by Elsevier in Pharmacological Research
- Vol. 100, 266-270
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- A CXCL1 Paracrine Network Links Cancer Chemoresistance and MetastasisCell, 2012
- Imaging Tumor-Stroma Interactions during Chemotherapy Reveals Contributions of the Microenvironment to ResistanceCancer Cell, 2012
- Monocytic CCR2+ Myeloid-Derived Suppressor Cells Promote Immune Escape by Limiting Activated CD8 T-cell Infiltration into the Tumor MicroenvironmentCancer Research, 2012
- The chemokine CCL18 causes maturation of cultured monocytes to macrophages in the M2 spectrumImmunology, 2011
- TGF-β Receptor II Loss Promotes Mammary Carcinoma Progression by Th17-Dependent MechanismsCancer Discovery, 2011
- Macrophage Binding to Receptor VCAM-1 Transmits Survival Signals in Breast Cancer Cells that Invade the LungsCancer Cell, 2011
- CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasisNature, 2011
- Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL–RANK signallingNature, 2011
- Inactivation of chemokine (C-C motif) receptor 1 (CCR1) suppresses colon cancer liver metastasis by blocking accumulation of immature myeloid cells in a mouse modelProceedings of the National Academy of Sciences, 2010
- Survival differences among women with de novo stage IV and relapsed breast cancerAnnals of Oncology, 2010